KZR-616 clinical development in three severe autoimmune diseases is advancing with several data readouts expected in 2021 and 2022 KZR-261 IND submission expected mid-2021, with Phase 1 trial in solid tumors expected to initiate before year-end Cash, cash equivalents and marketable securities of $142 million as of March 31, 2021… Read More..

LOS ANGELES, May 11, 2021 /PRNewswire/ -- LiveXLive Media (Nasdaq: LIVX) ("LiveXLive"), a global platform for livestream and on-demand audio, video and podcast/vodcast content in music, comedy and pop culture, and owner of PodcastOne, Slacker Radio, React Presents and Custom Personalization Solutions, announced today that its senior management will present at the 16th Annual Needham Virtual Technology & Media… Read More..

CUPERTINO, CA - May 10, 2021 - Aemetis, Inc.(NASDAQ: AMTX) announced that the company will host a conference call to review the release of its first quarter 2021 earnings report: Date:Wednesday, May 12, 2021 Time:11 am Pacific Standard Time (PST) Live Participant Dial In (Toll Free):+1-844-407-9500 Live Participant Dial In… Read More..